The Great Weight Race: Can New Contenders Navigate the Treacherous Path of Next-Gen Obesity Drugs?
The Pharma Gambit: Why Pfizer Might Just Snatch Metsara from Novo's Grasp
Pfizer's Pivotal Leap: BMO Analyst Seigerman Declares Bullish Outlook on Long-Awaited Obesity Market Entry via Metsara Deal
Pfizer's Bold Leap: Eyeing Metsara in Blockbuster Acquisition Bid